BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 19955219)

  • 1. E2F4 is required for cardiomyocyte proliferation.
    van Amerongen MJ; Diehl F; Novoyatleva T; Patra C; Engel FB
    Cardiovasc Res; 2010 Apr; 86(1):92-102. PubMed ID: 19955219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. E2F2 expression induces proliferation of terminally differentiated cardiomyocytes in vivo.
    Ebelt H; Zhang Y; Kampke A; Xu J; Schlitt A; Buerke M; Müller-Werdan U; Werdan K; Braun T
    Cardiovasc Res; 2008 Nov; 80(2):219-26. PubMed ID: 18628254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TWEAK is a positive regulator of cardiomyocyte proliferation.
    Novoyatleva T; Diehl F; van Amerongen MJ; Patra C; Ferrazzi F; Bellazzi R; Engel FB
    Cardiovasc Res; 2010 Mar; 85(4):681-90. PubMed ID: 19887380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F4 expression is required for cell cycle progression of normal intestinal crypt cells and colorectal cancer cells.
    Garneau H; Paquin MC; Carrier JC; Rivard N
    J Cell Physiol; 2009 Nov; 221(2):350-8. PubMed ID: 19562678
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiomyocyte cell cycle control and growth estimation in vivo--an analysis based on cardiomyocyte nuclei.
    Walsh S; Pontén A; Fleischmann BK; Jovinge S
    Cardiovasc Res; 2010 Jun; 86(3):365-73. PubMed ID: 20071355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The nucleocytoplasmic shuttling of E2F4 is involved in the regulation of human intestinal epithelial cell proliferation and differentiation.
    Deschênes C; Alvarez L; Lizotte ME; Vézina A; Rivard N
    J Cell Physiol; 2004 May; 199(2):262-73. PubMed ID: 15040009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-apoptotic function of the E2F transcription factor 4 (E2F4)/p130, a member of retinoblastoma gene family in cardiac myocytes.
    Dingar D; Konecny F; Zou J; Sun X; von Harsdorf R
    J Mol Cell Cardiol; 2012 Dec; 53(6):820-8. PubMed ID: 22985930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.
    Lu Z; Luo RZ; Peng H; Huang M; Nishmoto A; Hunt KK; Helin K; Liao WS; Yu Y
    Oncogene; 2006 Jan; 25(2):230-9. PubMed ID: 16158053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of E2F4 mitogenic activity during terminal differentiation by its heterodimerization partners for nuclear translocation.
    Puri PL; Cimino L; Fulco M; Zimmerman C; La Thangue NB; Giordano A; Graessmann A; Levrero M
    Cancer Res; 1998 Apr; 58(7):1325-31. PubMed ID: 9537223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A pocket pRb mutation induces the increase in its affinity to E2F4 coupled with activation of muscle differentiation].
    Popov BV; Watt SM; Rozanov IuM; Chang L-
    Mol Biol (Mosk); 2010; 44(2):323-34. PubMed ID: 20586193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear expression of E2F4 induces cell death via multiple pathways in normal human intestinal epithelial crypt cells but not in colon cancer cells.
    Garneau H; Alvarez L; Paquin MC; Lussier C; Rancourt C; Tremblay E; Beaulieu JF; Rivard N
    Am J Physiol Gastrointest Liver Physiol; 2007 Oct; 293(4):G758-72. PubMed ID: 17656449
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endothelial nitric oxide synthase promotes neonatal cardiomyocyte proliferation by inhibiting tissue inhibitor of metalloproteinase-3 expression.
    Hammoud L; Xiang F; Lu X; Brunner F; Leco K; Feng Q
    Cardiovasc Res; 2007 Jul; 75(2):359-68. PubMed ID: 17553475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle regulation in mouse heart during embryonic and postnatal stages.
    Ikenishi A; Okayama H; Iwamoto N; Yoshitome S; Tane S; Nakamura K; Obayashi T; Hayashi T; Takeuchi T
    Dev Growth Differ; 2012 Oct; 54(8):731-8. PubMed ID: 22957921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repression of fibroblast growth factor receptor 1 gene expression by E2F4 in skeletal muscle cells.
    Parakati R; Dimario JX
    Dev Dyn; 2005 Jan; 232(1):119-30. PubMed ID: 15580623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclin D1/cdk4 can interact with E2F4/DP1 and disrupts its DNA-binding capacity.
    Scimè A; Li L; Ciavarra G; Whyte P
    J Cell Physiol; 2008 Mar; 214(3):568-81. PubMed ID: 17894419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The TRAF-interacting protein (TRAIP) is a novel E2F target with peak expression in mitosis.
    Chapard C; Hohl D; Huber M
    Oncotarget; 2015 Aug; 6(25):20933-45. PubMed ID: 26369285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression patterns of the E2F family of transcription factors during murine epithelial development.
    Dagnino L; Fry CJ; Bartley SM; Farnham P; Gallie BL; Phillips RA
    Cell Growth Differ; 1997 May; 8(5):553-63. PubMed ID: 9149906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of cell cycle entry and cell death in postmitotic lens fiber cells by overexpression of E2F1 or E2F2.
    Chen Q; Hung FC; Fromm L; Overbeek PA
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4223-31. PubMed ID: 11095619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LEK1 protein expression in normal and dysregulated cardiomyocyte mitosis.
    Dees E; Robertson JB; Ashe M; Pabón-Peña LM; Bader D; Goodwin RL
    Anat Rec A Discov Mol Cell Evol Biol; 2005 Sep; 286(1):823-32. PubMed ID: 16047383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. E2F4 is required for early eye patterning.
    Ruzhynsky VA; Furimsky M; Park DS; Wallace VA; Slack RS
    Dev Neurosci; 2009; 31(3):238-46. PubMed ID: 19325228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.